AHCO - NASDAQ

AdaptHealth Corp.

AHCO·NASDAQ

$9.72

+0.73%

HealthcareMedical - Devices

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.32B

EPS-0.5200

P/E Ratio-18.69

Earnings Date08/04/2026

4.32B

Assets

-4%

3Y-17.0%

5Y+138.0%

10Y+1389583.0%

2.79B

Total Liabilities

-4%

3Y-9.0%

5Y+82.0%

10Y+974460.0%

1.53B

Total Equity

-3%

3Y-29.0%

5Y+443.0%

10Y-4580.0%

AdaptHealth Corp. Funding & Solvency Profile

AHCO · NASDAQ

Current Assets

Cash & Cash Equivalents106.14M

Net Receivables370.90M

Inventory151.25M

Other Current Assets0.00

Total Current Assets729 M

Non-Current Assets

Property, Plant & Equipment674.22M

Goodwill & Intangible Assets2.63B

Long-Term Investments0.00

Other Non-Current Assets19.12M

Total Non-Current Assets693 M

Total Assets

4.32B

Financial Health Analysis

Current Ratio

1.02x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Debt-to-Equity Ratio

1.83x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

17 M

Positive working capital, but relatively tight. The company should monitor cash flow carefully.

Asset Composition

17% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

AdaptHealth Corp. Balance Sheet

AHCO • NASDAQ

AdaptHealth Corp. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	106.1M	109.7M	77.1M	46.3M	149.6M	100M	76.9M	947.1K	119.8K
Cash & Short-Term Investments	106.1M	109.7M	77.1M	46.3M	149.6M	100M	76.9M	947.1K	119.8K
Net Receivables	370.9M	408M	388.9M	359.1M	359.9M	171.1M	78.6M	53M	0.0
Accounts Receivables	370.9M	408M	388.9M	359.1M	359.9M	171.1M	78.6M	53M	24.2M
Inventory	151.2M	139.8M	113.6M	127.8M	123.1M	58.8M	13.2M	7.7M	5M
Prepaids	100.6M	0.0	0.0	0.0	37.4M	33.4M	12.7M	158K	0.0
Other Current Assets	0.0	98.2M	69.3M	52.1M	0.0	0.0	0.0	-60.7M	0.0
Total Current Assets	728.9M	755.8M	649M	585.3M	670.1M	363.3M	181.4M	1.1M	119.8K
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	674.2M	618.4M	637.5M	622M	546.3M	110.5M	63.6M	61.6M	35.6M
Goodwill	2.5B	2.7B	2.7B	3.5B	3.5B	998.8M	266.8M	202.4M	38.6M
Intangible Assets	85.1M	105.5M	130.2M	162.8M	202.2M	116.1M	0.0	0.0	0.0
Goodwill & Intangible Assets	2.6B	2.8B	2.9B	3.7B	3.7B	1.1B	266.8M	202.4M	38.6M
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-276.9M	0.0
Tax Assets	267.8M	314.5M	345.9M	281.8M	304.2M	208.4M	27.9M	12.9M	0.0
Other Non-Current Assets	19.1M	17.6M	21.1M	22.4M	15.1M	16.5M	6.9M	253M	-74M
Total Non-Current Assets	3.6B	3.7B	3.9B	4.6B	4.6B	1.5B	365.1M	253M	190.8K
Total Assets	4.3B	4.5B	4.5B	5.2B	5.3B	1.8B	546.5M	254.1M	310.6K
LIABILITIES
CURRENT LIABILITIES
Total Payables	352.4M	284.6M	268.8M	222.5M	248M	191M	79.2M	199K	60.5K
Accounts Payable	352.4M	284.6M	211.5M	222.5M	248M	191M	79.2M	40.8K	60.5K
Other Payables	0.0	0.0	57.3M	0.0	0.0	0.0	0.0	158.2K	0.0
Accrued Expenses	0.0	153.4M	123.2M	115M	110.4M	63.2M	23.5M	500.4K	51.6K
Short Term Debt	20.3M	16.3M	53.4M	35M	20M	8.1M	1.7M	27.9M	174.2K
Capital Lease Obligations (Current)	48.4M	44.3M	38.4M	32.2M	46.9M	22.3M	19.8M	0.0	9.9M
Tax Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	158.2K	0.0
Deferred Revenue	0.0	34.9M	38.6M	31.6M	31.4M	11M	9.6M	7.5M	0.0
Other Current Liabilities	291.3M	33.5M	14.7M	19.9M	43.2M	126.4M	20.3M	-27.9M	-9.9M
Total Current Liabilities	712.4M	567M	537M	456.2M	499.8M	422.1M	154.1M	699.4K	286.3K
NON-CURRENT LIABILITIES
Long Term Debt	1.7B	2B	2.1B	2.2B	2.2B	776.6M	395.1M	127.1M	52.7M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-130.9M	0.0
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8M	0.0
Other Non-Current Liabilities	243.8M	272M	302.1M	344M	380.3M	334M	62.9M	-119.4M	-52.7M
Total Non-Current Liabilities	2.1B	2.3B	2.5B	2.6B	2.7B	1.1B	458.3M	7.9M	54.9M
Other Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-54.9M
Capital Lease Obligations	166.5M	149.2M	146.7M	140.6M	167M	22.3M	19.8M	172.5K	10.6M
Total Liabilities	2.8B	2.9B	3B	3.1B	3.2B	1.5B	612.3M	8.6M	286.3K
SHAREHOLDERS' EQUITY
Treasury Stock	-25.5M	-25.5M	-43.3M	-14M	0.0	0.0	0.0	0.0	0.0
Preferred Stock	1K	1K	1K	1K	1K	1K	0.0	0.0	0.0
Common Stock	13K	13K	13K	13K	13K	9K	7K	240.6M	719.0
Additional Paid-In Capital	2.2B	2.2B	2.1B	2.1B	2.1B	558.5M	0.0	2.9M	24.3K
Retained Earnings	-633M	-562.2M	-652.6M	26.3M	-43M	-199.2M	-40.3M	2.1M	-693.0
Accumulated Other Comprehensive Income/Loss	78K	2.3M	4.4M	8.7M	-2.4M	-4.4M	1.4M	0.0	0.0
Total Stockholders' Equity	1.5B	1.6B	1.5B	2.2B	2.1B	354.9M	-38.8M	245.5M	24.3K
Total Equity	1.5B	1.6B	1.5B	2.2B	2.1B	280.8M	-65.8M	248.4M	-34.1M
Minority Interest	7.8M	7M	8.2M	6.6M	4.8M	-74M	-27M	2.9M	-34.1M
SUMMARY
Total Liabilities & Equity	4.3B	4.5B	4.5B	5.2B	5.3B	1.8B	546.5M	254.1M	310.6K
Total Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-276.9M	0.0
Total Debt	1.9B	2.1B	2.3B	2.3B	2.4B	807M	416.8M	155.2M	174.2K
Net Debt	1.8B	2B	2.2B	2.3B	2.2B	707M	339.9M	154.2M	54.4K
Shares Outstanding	135,424,000	135,424,000	135,424,000	135,424,000	135,424,000	135,424,000	135,424,000	135,424,000	135,424,000

SEC Filings

AHCO - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K/A 8-K/A 2026 (Amended) N/A	June 02, 2026	May 04, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 05, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 28, 2026	June 18, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 13, 2026	April 10, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 24, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 24, 2026	February 24, 2026	2026	View Filing
10-Q 10-Q 2025 Q3 Q3	November 04, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 04, 2025	November 04, 2025	2025	View Filing
10-Q 10-Q 2025 Q2 Q2	August 05, 2025	June 30, 2025	2025	View Filing

Showing 1 to 10 of 165 filings

Related Guides

Blog Categories

Continue your AHCO research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.